626 Financial LLC Has $306,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

626 Financial LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 69.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 583 shares of the healthcare conglomerate's stock after selling 1,350 shares during the period. 626 Financial LLC's holdings in UnitedHealth Group were worth $306,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in UNH. Norges Bank acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $6,375,744,000. GAMMA Investing LLC raised its holdings in shares of UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares during the period. Raymond James Financial Inc. acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $1,914,740,000. Amundi raised its holdings in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock worth $3,183,132,000 after acquiring an additional 2,991,470 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of UnitedHealth Group by 36.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after acquiring an additional 2,301,010 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CFO John F. Rex acquired 17,175 shares of the company's stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the purchase, the chief financial officer now directly owns 203,796 shares of the company's stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now directly owns 6,033 shares of the company's stock, valued at $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock worth $31,607,768 over the last 90 days. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Down 1.6%

UnitedHealth Group stock opened at $295.61 on Friday. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The firm has a market capitalization of $268.16 billion, a price-to-earnings ratio of 19.07, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a 50 day simple moving average of $413.43 and a 200 day simple moving average of $486.09.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the prior year, the firm posted $6.91 earnings per share. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.99%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is currently 35.18%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on UNH shares. Deutsche Bank Aktiengesellschaft lowered their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Piper Sandler reduced their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research report on Tuesday. KeyCorp reduced their price objective on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a research report on Monday. Finally, Hsbc Global Res downgraded shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. One analyst has rated the stock with a sell rating, seven have issued a hold rating and seventeen have assigned a buy rating to the company's stock. According to MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus target price of $428.43.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.